Dehydroepiandrosterone
Spécifications
53-43-0Numéro CAS
200-175-5Numéro CE
(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-oneNom IUPAC
C19H28O2Formule chimique
288.4 g/molMasse molaire
Dehydroepiandrosterone; DHEA; PRASTERONE; 53-43-0; Dehydroisoandrosterone; Androstenolone; Diandron; 3beta-hydroxyandrost-5-en-17-one; 17-Hormoforin; Intrarosa; Prasterona; 3-beta-Hydroxy-5-androsten-17-one; Prasteronum; Vaginorm; 5,6-Dehydroisoandrosterone; Biolaif; EM-760; DTXSID4020379; NSC-9896; Androst-5-en-17-one, 3-hydroxy-, (3beta)-; NSC9896; 459AG36T1B; (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one; DTXCID40379; CHEBI:28689; Fidelin; Prastera; Natrol dhea; Enzymatic therapy; GL701; (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta(a)phenanthren-17-one; Prasterone, 3 alpha; prasterone and ibuprofen; RefChem:55906; 5 Androsten 3 ol 17 one; DHEA (Dehydroepiandrosterone); Therapeutic Dehydroepiandrosterone; A14AA07; G03XX01; 5 Androsten 3 beta hydroxy 17 one; 5-Androsten-3-beta-hydroxy-17-one; 200-175-5; trans-Dehydroandrosterone; Diandrone; Psicosterone; 17-Chetovis; Prestara; Andrestenol; 5-Dehydroepiandrosterone; Dehydro-epi-androsterone; Siscelar plus; (+)-Dehydroisoandrosterone; 5,6-Didehydroisoandrosterone; dehydroepiandrosterone (dhea); Epiandrosterone, 5-dehydro-; Caswell No. 051F; 5,6-Dehydroisoandrostorone; 3beta-hydroxy-5-androsten-17-one; Astenile; CCRIS 3277; Deandros; (3-beta)-3-Hydroxyandrost-5-en-17-one; DEHYDROISOANDOSTERONE; GL 701; dehydroepiandosterone; EPA Pesticide Chemical Code 126510; 5-Androsten-3beta-ol-17-one; NSC 9896; Androst-5-en-17-one, 3-hydroxy-, (3.beta.)-; (3beta)-3-hydroxyandrost-5-en-17-one; Androst-5-en-17-one, 3-beta-hydroxy-; CHEMBL90593; D5-Androsten-3beta-ol-17-one; Androst-5-ene-3beta-ol-17-one; 3beta-Hydroxy-D5-androsten-17-one; 3-beta-hydroxyandrost-5-en-17-one; (3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-3,4,7,8,9,10,11,12,13,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one; Dehydro Epiandrosterone; AND; Prasterone [INN]; MFCD00003613; Prasteronum [INN-Latin]; Prasterona [INN-Spanish]; CAS-53-43-0; (1S,5S,11S,15S,2R,10R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0<2,7>.0<11,15> ]heptadec-7-en-14-one; SMR000059075; Androst-5-en-17-one, 3.beta.-hydroxy-; SR-01000075815; Prasterone [USAN:INN]; EINECS 200-175-5; Dehydro Epiandrosterone (1.0 mg/mL in Acetonitrile); BRN 2058110; 5-Androsten-3.beta.-ol-17-one; Anastar; Inflabloc; Aslera; UNII-459AG36T1B; Fidelin T; Androst-5-en-17-one, 3-hydroxy-, (3b)-; DHEA; Prasterone; NCGC00093802-04; NCGC00093802-06; Biolaif (TN); Androst-5-en-17-one, 3beta-hydroxy-; dehydroepiandrostenedione; 5-dehydro-Epiandrosterone; Prasterone (USAN/INN); trans-de-hydroandrosterone; PRASTERONE [USAN]; bmse000665; EC 200-175-5; Dehydroisoandrosterone(Dhea); PRASTERONE [MART.]; Prasterone, (3.alpha.)-; Androsten-3beta-ol-17-one; PRASTERONE [WHO-DD]; Androst-5-en-17-one, 3-hydroxy-, (3-beta)-; BIDD:PXR0080; Lopac0_000368; SCHEMBL24156; 4-08-00-00994 (Beilstein Handbook Reference); MLS001066350; MLS001333231; MLS001333232; MLS001424274; orb180847; 5-Androsten-3B-ol-17-one; D5-Androsten-3b-ol-17-one; GTPL2370; Androst-5-ene-3b-ol-17-one; PRASTERONE [ORANGE BOOK]; SCHEMBL27464949; 3b-Hydroxyandrost-5-en-17-one; 5-Androsten-3-beta-ol-17-one; MSK2264; 3b-Hydroxy-D5-androsten-17-one; 3beta-Hyroxyandrost-5-en-17-one; DEHYDROEPIANDROSTERONE [MI]; EL-10; HMS2052P11; HMS2090C04; HMS2232K11; IM 28; trans-Dehydroandrosterone, >=99%; 3-beta-hydroxy-5-androsten-17-on; IPL-1001; 3beta-hydroxy-androst-5-en-17-one; 3beta-Hydroxyandrost-5-ene-17-one; Tox21_111222; Tox21_201996; Tox21_302761; Androst-5-en-3.alpha.-ol-17-one; BDBM50223368; CMC_13435; Delta5-androsten-3-beta-ol-17-one; DL-373; GL-701; LMST02020021; MSK2264-100A; PB-007; s2604; SBB012501; DEHYDROEPIANDROSTERONE [VANDF]; 3.beta.-Hydroxyandrost-5-en-17-one; 5-Androsten-3beta-ol-17-one; DHEA; AKOS007930299; AKOS015951378; MSK2264-1000A; Tox21_111222_1; CCG-101190; CS-1667; DB01708; FD12003; GS-0906; IP-1001; NC00440; SH-K-04828; NCGC00093802-09; NCGC00093802-14; NCGC00256412-01; NCGC00259545-01; (3beta)-3-Hydroxyandrost-5-ene-17-one; AC-28716; HY-14650; NCI60_042215; Prasterone (DHEA; Dehydroepiandrosterone); ST069381; (3beta)-3-hydroxy-Androst-5-en-17-one; EU-0100368; NS00000508; Androst-5-en-17-one, 3beta-hydroxy- (8CI); C01227; D 4000; D-0340; D08409; (3alpha,8alpha)-3-hydroxyandrost-5-en-17-one; AB00375810-06; AB00375810_09; Dehydroepiandrosterone (DHEA), 1mg/ml in Methanol; Q408376; SR-01000075815-1; SR-01000075815-4; BRD-K41256143-001-12-7; (3beta,16alpha)-3,16-dihydroxy-androst-5-en-17-one; Androst-5-en-17-one, 3-hydroxy-, (3beta)- (9CI); 1A9D2040-240C-427D-ADE4-0CB700B785CB; Dehydroepiandrosterone Solution in Acetonitrile, 1000ug/mL; Dehydroepiandrosterone Solution in Acetonitrile, 100ug/mL; Prasterone (DHEA; Dehydroepiandrosterone) 1.0 mg/ml in Acetonitrile; (1S,2R,5S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-one; (3S,8R,10R,13S)-3-Hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one; 105597-37-3Synonymes
Produits contenant Dehydroepiandrosterone
Prasterone - Symbiotec PharmalabPrasteroneDehydroepiandrosteroneDHEA/DehydroepiandrosteroneDHEADehydroepiandrosterone [DHEA]DehydroepiandrosteronedehydroepiandrosteroneDehydroepiandrosteroneDehydroEpiandrosterone (DHEA)Abiraterone Acetate int 53-43-098% up GMP DMF Dehydroepiandrosterone 53-43-0
Page 1 sur 2
Entreprises vendant Dehydroepiandrosterone
HD
Hangzhou Dingyan Chem Co., LtdChinaSI
Sinoway Industrial Co.Ltd.ChinaZE
Zhejiang Eazy Pharmchem Co., Ltd.ChinaQB
Qingdao BNP BioScienceChinaZS
Zhejiang Shenzhou Pharmaceutical Co., Ltd.ChinaSJ
Shanghai Jinli Pharmaceutical Co.,Ltd.ChinaTE
TIANJIN ENJU BIOTECHNOLOGY CO., LTD.ChinaPQ
Productos Quimicos NaturalesMexicoSI
SINOPHARM INTERNATIONAL TECHNOLOGY LIMITED COMPANYChina